| (84) |
Designated Contracting States: |
|
AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU LV MC NL PL PT RO SE
SI SK TR |
|
Designated Extension States: |
|
HR |
| (30) |
Priority: |
22.12.2005 GB 0526121
31.05.2006 GB 0610706
|
| (43) |
Date of publication of application: |
|
24.09.2008 Bulletin 2008/39 |
| (73) |
Proprietor: AstraZeneca AB |
|
151 85 Södertälje (SE) |
|
| (72) |
Inventors: |
|
- WEDGE, Stephen, Robert
Cheshire SK10 4TG (GB)
- RYAN, Anderson, Joseph
Cheshire SK10 4TG (GB)
|
| (56) |
References cited: :
|
| |
|
|
- HUBER PETER E ET AL: "Trimodal cancer treatment: Beneficial effects of combined antianglogenesis,
radiation, and chemotherapy" CANCER RESEARCH, vol. 65, no. 9, May 2005 (2005-05),
pages 3643-3655,3633, XP002464232 ISSN: 0008-5472
- BISCHOF M ET AL: "Triple combination of irradiation, chemotherapy (pemetrexed), and
VEGFR inhibition (SU5416) in human endothelial and tumor cells" INTERNATIONAL JOURNAL
OF RADIATION: ONCOLOGY BIOLOGY PHYSICS, PERGAMON PRESS, US, vol. 60, no. 4, 15 November
2004 (2004-11-15), pages 1220-1232, XP004618608 ISSN: 0360-3016
- GLADE-BENDER J ET AL: "VEGF BLOCKING THERAPY IN THE TREATMENT OF CANCER" EXPERT OPINION
ON BIOLOGICAL THERAPY, ASHLEY, LONDON, GB, vol. 3, no. 2, April 2003 (2003-04), pages
263-276, XP009060849 ISSN: 1471-2598
- SRIDHAR SRIKALA S ET AL: "Targeting angiogenesis: a review of angiogenesis inhibitors
in the treatment of lung cancer." LUNG CANCER (AMSTERDAM, NETHERLANDS) DEC 2003, vol.
42 Suppl 1, December 2003 (2003-12), pages S81-S91, XP002464233 ISSN: 0169-5002
|
|
